TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
IMRX

Immuneering Corp

Healthcare · Biotechnology

4.00$ -0.7% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow IMRX
Line item 2019 2020 2021 2022 2023 2024 2025
-231.4% -632.5% -1,483.2% -13,914.2% -10,762,337.1% – –
0.9% 3.4% 7.6% 87.5% 77,380.9% – –
31.1% 47.0% 86.7% 1,282.4% 1,258,711.0% – –
146.5% 47.0% 71.9% 1,284.0% – – –
22.8% 54.2% 43.3% 541.8% -214,206.8% – –
1.1% 2.3% 2.9% 234.3% 75,328.8% – –
-1.1% -2.3% -3,635.5% 13,197.9% 1,603,624.6% – –
– – 6,935.9% 6.0% – – –
199.2% – – – – – –
894.5% 1,643.2% 6,935.9% 6.0% 6,250,785.3% – –
662.0% 1,008.3% 1,817.2% -710.3% -2,907,927.3% – –
-232.5% -634.8% -1,486.2% -14,148.4% -10,837,665.9% – –

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?